These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9174048)

  • 1. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard.
    Fan S; Chang JK; Smith ML; Duba D; Fornace AJ; O'Connor PM
    Oncogene; 1997 May; 14(18):2127-36. PubMed ID: 9174048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
    Fan S; Smith ML; Rivet DJ; Duba D; Zhan Q; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Apr; 55(8):1649-54. PubMed ID: 7712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin.
    Smith ML; Kontny HU; Zhan Q; Sreenath A; O'Connor PM; Fornace AJ
    Oncogene; 1996 Nov; 13(10):2255-63. PubMed ID: 8950993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.
    McDonald ER; Wu GS; Waldman T; El-Deiry WS
    Cancer Res; 1996 May; 56(10):2250-5. PubMed ID: 8625293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
    Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
    Hawkins DS; Demers GW; Galloway DA
    Cancer Res; 1996 Feb; 56(4):892-8. PubMed ID: 8631030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
    Cistulli CA; Kaufmann WK
    Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
    Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
    Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
    Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC
    J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.
    Bilim V; Kawasaki T; Takahashi K; Tomita Y
    J Exp Clin Cancer Res; 2000 Dec; 19(4):483-8. PubMed ID: 11277327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
    Fan S; Cherney B; Reinhold W; Rucker K; O'Connor PM
    Clin Cancer Res; 1998 Apr; 4(4):1047-54. PubMed ID: 9563901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
    Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
    Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
    Bartussek C; Naumann U; Weller M
    Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
    Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
    Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
    Le NT; Richardson DR
    Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1).
    Yang F; von Knethen A; Brüne B
    J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
    Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
    Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.